首页> 外文期刊>European review for medical and pharmacological sciences. >Application value of procalcitonin in patients with central nervous system infection
【24h】

Application value of procalcitonin in patients with central nervous system infection

机译:降钙素原在中枢神经系统感染患者中的应用价值

获取原文
           

摘要

OBJECTIVE: To study the application value of procalcitonin (PCT) in patients with central nervous system (CNS) infection. PATIENTS AND METHODS: A total of 66 patients, including 24 patients with suppurative meningitis, 20 patients with viral meningitis and 22 patients with tuberculous meningitis, were enrolled. 20 patients admitted to the hospital due to epilepsy or headache without infection in the same period were enrolled as the control group. PCT, high-sensitivity C-reactive protein (Hs-CRP), high-sensitivity C-reactive protein (Hs-CRP), protein quantification, chloride and glucose in serum and cerebrospinal fluid, were collected. RESULTS: The serum PCT level in suppurative meningitis group was significantly higher than that in other three groups. The dynamic monitoring of suppurative meningitis group on admission, at 72 h and 1 week after treatment showed that the serum PCT level was significantly decreased. PCT levels in cerebrospinal fluid in suppurative meningitis group, viral meningitis group and tuberculous meningitis group were decreased successively, and the differences were statistically significant. The detection of PCT in cerebrospinal fluid was more valuable than serum PCT detection in distinguishing tuberculous meningitis from viral meningitis. Continuous monitoring of changes in PCT in cerebrospinal fluid showed that there was no statistically significant difference before and after treatment. PCT level in cerebrospinal fluid was positively correlated with the serum PCT, cerebrospinal fluid white blood cell (WBC), and protein content in cerebrospinal fluid. CONCLUSIONS: The dynamic changes of serum PCT in patients with suppurative meningitis can be used to evaluate the disease, guide the clinical medication, and monitor the prognosis.
机译:目的:探讨降钙素原(PCT)在中枢神经系统(CNS)感染患者中的应用价值。患者与方法:共纳入66例患者,其中包括24例化脓性脑膜炎,20例病毒性脑膜炎和22例结核性脑膜炎。同期纳入因癫痫或头痛而无感染入院的20例患者作为对照组。收集了PCT,高敏C反应蛋白(Hs-CRP),高敏C反应蛋白(Hs-CRP),蛋白质定量,血清和脑脊液中的氯化物和葡萄糖。结果:化脓性脑膜炎组血清PCT水平明显高于其他三组。化脓性脑膜炎组入院时,治疗后72 h和1周的动态监测显示,血清PCT水平显着降低。化脓性脑膜炎组,病毒性脑膜炎组,结核性脑膜炎组脑脊液中PCT水平依次下降,差异有统计学意义。在区分结核性脑膜炎与病毒性脑膜炎方面,脑脊液中PCT的检测比血清PCT检测更有价值。连续监测脑脊液中PCT的变化表明,治疗前后无统计学差异。脑脊液中的PCT水平与血清​​PCT,脑脊液白细胞(WBC)和脑脊液中的蛋白质含量呈正相关。结论:化脓性脑膜炎患者血清PCT的动态变化可用于评估疾病,指导临床用药和监测预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号